The Association for Diagnostics & Laboratory Medicine – (ADLM | AACC) 2025

27 — 31 July 2025

Join Meridian Bioscience at ADLM 2025 at booth #3620 | July 29–31, 2025 | McCormick Place, Chicago, IL

Meridian Bioscience is excited to exhibit at the Association for Diagnostics & Laboratory Medicine (ADLM) 2025 Clinical Lab Expo—the leading global event for laboratory diagnostics and clinical innovation. Drop by our booth, #3620 to explore Meridian’s end-to-end immunoassay and molecular reagent solutions—powering assay development from early-stage design through to commercialization.

Comprehensive Reagent Solutions for Molecular and Immunoassay Development

Whether you’re advancing infectious disease testing, oncology panels, or point-of-care diagnostics, our reagents are designed to optimize performance, simplify workflows, and reduce supply chain risk.

Molecular Diagnostic Reagents & Custom Services
Streamline your workflow with a comprehensive portfolio of molecular components for qPCR, isothermal amplification, and NGS applications.

•
Enzymes & Polymerases

Glycerol-free, inhibitor-tolerant enzymes engineered for high performance in challenging clinical samples (e.g., FFPE, plasma)

•
Master Mixes

Highly sensitive, lyophilization-ready mixes optimized for qPCR, LAMP, and NGS

•
Nucleotides & Oligos

Ultra-pure dNTPs for reliable amplification and assay consistency

•
Extraction & Process Controls

Designed to verify sample integrity, monitor workflow efficiency, and ensure result traceability across diverse sample types

Immunoassay Reagents & Custom Services

Develop highly sensitive immunoassay assays with lot-to-lot consistency with immunodiagnostic components manufactured to exacting quality standards:
Build sensitive, reliable immunoassays with lot-to-lot consistency using components manufactured to the highest quality standards:

We have everything you need to:

•Paired Antibodies – High-affinity antibodies for over 150 disease targets
•Native & Recombinant Antigens – Optimized for sensitive detection of IgG and IgM antibody responses
•Immunoassay Blockers – Minimize false results from HAMA, RF, and heterophilic antibody interference
•Custom Antibody & Protein Services – Flexible development and scalable manufacturing tailored to your assay needs

Why partner with Meridian?

•
Decades of Enzyme Expertise

Proven know-how to make your enzyme glycerol-free

•
Single source solution

All your assay reagents from one trusted partner

•
Flexible Customization Services

We extend your R&D capacity with scalable, fit-for-purpose solutions.

ADLM

Don’t miss our Featured Poster Presentation!

Location: Poster #B-221 | ADLM Poster Hall
Date & Time: Wednesday, July 30, 2025 | 1:30 PM – 2:30 PM (Presentation)
Poster Display: 9:30 AM – 5:00 PM

Presenter: Thomas Fouqueau, Manager, R&D
Session Topic: Molecular Diagnostics and Genetics

Title: Development of a Rapid, Sensitive, and Specific RNA Amplification Method for Point-of-Care Detection of Tuberculosis

Early and accurate diagnosis of tuberculosis (TB) remains a global health challenge, particularly in low-resource settings. This study evaluated the feasibility of detecting M. tuberculosis RNA directly from minimally processed biofluids—saliva, sputum, and blood—using NASBA with molecular beacon-based real-time detection under isothermal conditions. The approach showed strong potential for rapid, sensitive TB detection at the point of care, with results delivered in under 30 minutes.

About the Speaker

Thomas Fouqueau, Ph.D. is an R&D Manager for Meridian Life Science.

Thomas obtained a Ph.D. in 2013 in biochemistry and molecular biology
while studying the catalytic activities of thermostable RNA polymerases at
University of Regensburg, Germany. He later extended his research interest by
exploring the global modulation of cellular transcriptio11 by viral i11fection
in extremophiles using structural and genomic approaches at University
College London, UK. With over 12 years’ experience working with and
optimizing qPCR and LAMP assays, Thomas now runs a team focused
on developing new innovative qPCR and LAMP mixes used by the global
diagnostic industry for the development of diagnostic kits.